53 related articles for article (PubMed ID: 27740534)
21. Ursodeoxycholic acid for primary biliary cirrhosis.
Drug Ther Bull; 1999 Apr; 37(4):30-2. PubMed ID: 10563063
[TBL] [Abstract][Full Text] [Related]
22. FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Alawad AS; Levy C
Dig Dis Sci; 2016 Dec; 61(12):3395-3404. PubMed ID: 27734248
[No Abstract] [Full Text] [Related]
23. Eosinophils and primary biliary cirrhosis-stoking the fire?
Neuberger J
Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
[No Abstract] [Full Text] [Related]
24. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
25. Use of ursodeoxycholic acid in liver diseases.
Kumar D; Tandon RK
J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.
Cheng K; Ashby D; Smyth R
J R Soc Med; 1997; 90 Suppl 31(Suppl 31):6-12. PubMed ID: 9204005
[No Abstract] [Full Text] [Related]
27. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
28. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
Alenezi B; Lamoureux E; Alpert L; Szilagyi A
Dig Dis Sci; 2005 Jan; 50(1):196-200. PubMed ID: 15712660
[No Abstract] [Full Text] [Related]
29. [Treatment of primary biliary cirrhosis].
Szalay F
Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
[No Abstract] [Full Text] [Related]
30. Ursodeoxycholic acid for primary biliary cirrhosis.
Gluud C; Christensen E
Cochrane Database Syst Rev; 2002; (1):CD000551. PubMed ID: 11869580
[TBL] [Abstract][Full Text] [Related]
31. Primary biliary cirrhosis.
Kaplan MM; Gershwin ME
N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
[No Abstract] [Full Text] [Related]
32. Primary biliary cirrhosis: therapeutic advances.
Czul F; Peyton A; Levy C
Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
[TBL] [Abstract][Full Text] [Related]
33. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
Trauner M; Graziadei IW
Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
[TBL] [Abstract][Full Text] [Related]
34. [Primary biliary cirrhosis: therapeutic options].
Abenavoli L
Recenti Prog Med; 2009 Sep; 100(9):417-23. PubMed ID: 19886235
[TBL] [Abstract][Full Text] [Related]
35. The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense.
Van Den Bogaert E; Francque S; Pelckmans P; Michielsen P
Acta Gastroenterol Belg; 2003; 66(4):283-7. PubMed ID: 14989050
[TBL] [Abstract][Full Text] [Related]
36. Ursodeoxycholic acid therapy in hepatobiliary disease.
Kowdley KV
Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
[TBL] [Abstract][Full Text] [Related]
37. Primary Biliary Cirrhosis Beyond Ursodeoxycholic Acid.
Corpechot C
Semin Liver Dis; 2016 Feb; 36(1):15-26. PubMed ID: 26870929
[TBL] [Abstract][Full Text] [Related]
38. [A case of primary biliary cirrhosis associated with fatty liver following delivery].
Nakamura T; Omagari K; Kinoshita H; Matsuo I; Shirono K; Egawa I; Komatsu K; Yamasaki Y; Kohno S
Nihon Shokakibyo Gakkai Zasshi; 1997 Aug; 94(8):558-63. PubMed ID: 9284447
[No Abstract] [Full Text] [Related]
39. [Good prognosis in asymptomatic primary biliary cirrhosis].
Lööf L; Lindgren S
Lakartidningen; 2010 May 26-Jun 1; 107(21):1396-8. PubMed ID: 20645617
[No Abstract] [Full Text] [Related]
40. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
